Overview
Ryszard Swoboda practices in Gliwice, Poland. Mr. Swoboda is rated as an Advanced expert by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). His top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Leukemia, Graft Versus Host Disease (GvHD), Acute Myeloid Leukemia (AML), and Bone Marrow Transplant.
His clinical research consists of co-authoring 20 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 5 articles in the study of Acute Lymphoblastic Leukemia (ALL).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Acute Lymphoblastic Leukemia (ALL)Mr. Swoboda isAdvanced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Bone Marrow TransplantMr. Swoboda isAdvanced. Learn about Bone Marrow Transplant.
- Experienced
- Acute Myeloid Leukemia (AML)Mr. Swoboda isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Cutaneous T-Cell Lymphoma (CTCL)Mr. Swoboda isExperienced. Learn about Cutaneous T-Cell Lymphoma (CTCL).
- Graft Versus Host Disease (GvHD)Mr. Swoboda isExperienced. Learn about Graft Versus Host Disease (GvHD).
- Hodgkin LymphomaMr. Swoboda isExperienced. Learn about Hodgkin Lymphoma.
- LeukemiaMr. Swoboda isExperienced. Learn about Leukemia.
- Lymphofollicular HyperplasiaMr. Swoboda isExperienced. Learn about Lymphofollicular Hyperplasia.